4
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Future Aspects on Inflammatory Bowel Disease

Pages 87-90 | Published online: 08 Jul 2009

References

  • Gilat T, Hacohen D, Lilos P, Langman M JS. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol 1987; 22: 1009–24
  • Persson P G, Leijonmarck C E, Bernell O, Hellers G, Ahlbom A. Risk indicators for inflammatory bowel disease. Int J Epidemiol 1993; 22: 268–72
  • Gent A E, Hellier M D, Grace R H, Swarbrick E T, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994; 343: 766–7
  • Ekbom A, Adami H O, Helmick C G, Jonzon A, Zack M M. Perinatal risk factors for inflammatory bowel disease: a case-control study. Am J Epidemiol 1990; 132: 1111–19
  • Whorwell P J, Holdstock G, Whorwell G M, Wright R. Bottle feeding, early gastroenteritis, and inflammatory bowel disease. Br Med J 1979; 1: 382
  • Wakefield A J, Lewin J, Dhillon A P, Sim R, Pounder R E. Confirmation of persistent measles virus infection of intestinal tissue by immunogold electron microscopy. Gut 1995; 36: 564–9
  • Ekbom A, Wakefield A J, Zack M, Adami H O. The role of perinatal measles infection in the etiology of Crohn's disease: a population-based epidemiological study. Lancet 1994; 344: 508–10
  • Lindberg E, Järnerot G. The incidence of Crohn's disease is not decreasing in Sweden. Scand J Gastroenterol 1991; 26: 495–500
  • Tysk C, Järnerot G. Seasonal variation in exacerbations of ulcerative colitis. Scand J Gastroenterol 1993; 28: 95–6
  • Rutgeerts P, D'Haens G, Hiele M, Geboes K, Vantrappen G. Appendectomy protects against ulcerative colitis. Gastroenterology 1994; 106: 1251–3
  • Logan R FA, Duggan A E, Usmani J, Neal K R. Appendectomy, tonsillectomy and risk of inflammatory bowel disease [abstract]. Gastroenterology 1995; 108: A865
  • Groisman G M, George J, Harpaz N. Ulcerative appendicitis in universal and nonuniversal ulcerative colitis. Modern Pathol 1994; 7: 322–5
  • Andresen A FR. Gastrointestinal manifestations of food allergy. Med J Rec Suppl 1925; 122: 271–5
  • Panza E, Franceshi S, La Vecchia S, Parrazzini F, Petrillo M, Decarli A, Bianchi Porro G. Dietary factors in the aetiology of inflammatory bowel disease. Ital J Gastroenterol 1987; 19: 205–9
  • Persson P G, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: a case-control study. Epidemiology 1992; 3: 47–52
  • Lindberg E, Tysk C, Andersson K, Järnerot G. Smoking and inflammatory bowel disease. A case control study. Gut 1988; 29: 352–7
  • Lindberg E, Järnerot G, Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut 1992; 33: 779–82
  • Cottone M, Rosseli M, Orlando A, Oliva L, Puelo A, Cappelo M, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994; 106: 643–8
  • Vessey M, Jewell D, Smith A, Yeates D, McPherson K. Chronic inflammatory bowel disease, cigarette smoking, and use of oral contraceptives: findings in a large cohort study of women of child-bearing age. Br Med J 1986; 292: 1101–3
  • Gaffney P R, Cuimin T D, Gaffney A, Hogan J, Hayes D P, Annis P. Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol 1995; 90: 220–3
  • Lorenz R, Born P, Olbert P, Classen M. Factor XIII substitution in ulcerative colitis [letter]. Lancet 1995; 345: 449–50
  • Thompson N P, Wakefield A J, Pounder R E. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 1995; 108: 1011–5
  • Monsøn U, Iselius L, Johansson C, Hellers G. Evidence for a major additive gene in ulcerative colitis. Clin Genet 1989; 36: 411–4
  • Orrholm M, Iselius L, Sörensen T IA, Munkholm P, Langholz E, Binder V. Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. Br Med J 1993; 306: 20–4
  • Tysk C, Lindberg E, Järnerot G, Flodørus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988; 29: 990–6
  • Shanahan F, Duerr R H, Rotter J I, Yang H, Sutherland L R, McElree C, et al. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 1992; 103: 456–61
  • Yang P, Järnerot G, Danielsson D, Tysk C, Lindberg E. PANCA in monozygotic twins with inflammatory bowel disease. Gut 1995; 36: 887–90
  • Tsai H H, Dwarakanath A D, Hart C A, Milton J D, Rhodes J M. Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment. Gut 1995; 36: 570–6
  • Kruis W, Schötz E, Stolte M, Fixa B, Kralove H, Fric P, Judmaier G. Double-blind comparison between mesalamine (Salofalk) and a preparation of viable E. coli Nissle (Mutafior) for maintenance therapy of ulcerative colitis [abstract]. Gastroenterology 1917–1995; 108: A853
  • Srivastava E D, Record C O, Green J, Allison M C, Williams G T, Dettmar P W, et al. Effect of Carbopol 934P on the clinical course of active ulcerative colitis [abstract]. Gastroenterology 1995; 108: A899
  • Helgeland L, Tysk C, Järnerot G, Kett K, Lindberg E, Danielsson D, et al. IgG subclass distribution in serum and rectal mucosa of monozygotic twins with or without inflammatory bowel disease. Gut 1992; 33: 1358–64
  • Harper P H, Lee E CG, Kettlewell M GW, Bennett B K, Jewell D P. Role of the faecal stream in the maintenance of Crohn's disease. Gut 1985; 26: 279–84
  • Hollander D, Vadheim C M, Brettholz E, Petersen G, Delahunty T, Rotter J. Increased intestinal permeability in patients with Crohn's disease and their relatives. Ann Intern Med 1986; 105: 883–5
  • Munkholm P, Langholz E, Hollander D, Thornberg K, Orholm M, Katz K D, Binder V. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first-degree relatives. Gut 1994; 35: 68–72
  • Lindberg E, Söderholm J D, Olaison G, Tysk C, Järnerot G. Intestinal permeability to polyethylene glycols in monozygotic twins with Crohn's disease. Scand J Gastroenterol 1995; 30: 780–83
  • Stronkhorst A, Tytgat G NJ, van Deventer S JH. CD4 antibody treatment in Crohn's disease. Scand J Gastroenterol 1992; 27 Suppl 194: 61–5
  • Van Dullemen H M, van Deventer S JH, Hommes D W, Bejl H A, Jansen J, Tytgat G NJ, Woody J. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995; 109: 129–35

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.